MarketCap
Facebook
X
TelegramQuartalsbericht 2025-Q4
hinzugefügt 17.02.2026
CEL-SCI Corporation Anteile 2011-2026 | CVM
Anteile Jährlich CEL-SCI Corporation
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 63.8 M | 47.4 M | 43.4 M | 40.7 M | 36.8 M | 31.2 M | 17 M | 7.89 M | 4.87 M | 3.3 M | 2.35 M | 1.21 M | 1.01 M | 834 K |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 63.8 M | 834 K | 21.6 M |
Anteile Vierteljährlich CEL-SCI Corporation
| 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 8.42 M | 8.02 M | 5.32 M | 84.3 M | 74.1 M | 2.13 M | 54.3 M | 54.1 M | 50 M | 47.4 M | 44.7 M | 43.8 M | 43.4 M | 43.4 M | 43.2 M | 43.1 M | 43.1 M | 39.9 M | 41 M | 40 M | 38.7 M | 36.2 M | 37.5 M | 38.7 M | 35.1 M | 33.1 M | 29.1 M | 35.1 M | 28 M | 14.5 M | 16.7 M | 28 M | 11.6 M | 7.24 M | 8.41 M | 11.6 M | 5.99 M | 5.37 M | 4.97 M | 5.99 M | 4.39 M | 3.88 M | 3.35 M | 110 M | 2.93 M | 66.1 M | 64.7 M | 89 M | 48.2 M | 30 M | 30.9 M | 48.2 M | 28.3 M | 245 M | 258 M | 283 M | 229 M | 207 M | 208 M | 229 M |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 283 M | 2.13 M | 57.2 M |
Anteile anderer Aktien in der Pharmaeinzelhändler
| Name | Anteile | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
MorphoSys AG
MOR
|
33.4 M | - | 2.43 % | $ 254 M |  Germany |
 |
Apellis Pharmaceuticals
APLS
|
126 M | $ 20.7 | -1.24 % | $ 2.61 B |  USA |
 |
Aptorum Group Limited
APM
|
5.45 M | $ 0.84 | - | $ 4.58 M |  China |
 |
Axsome Therapeutics
AXSM
|
49.7 M | $ 166.38 | - | $ 8.28 B | USA |
 |
I-Mab
IMAB
|
187 M | - | - | $ 866 M | China |
 |
Burford Capital Limited
BUR
|
219 M | $ 8.73 | 3.44 % | $ 1.36 B |  Britain |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
219 M | - | - | $ 40.3 B | USA |
 |
Biophytis SA
BPTS
|
118 M | - | -13.47 % | $ 169 M |  France |
 |
AbCellera Biologics
ABCL
|
299 M | $ 3.82 | - | $ 1.14 B |  Canada |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
4.58 M | - | -1.52 % | $ 24.7 M | USA |
 |
Midatech Pharma plc
MTP
|
80.5 M | - | -18.52 % | $ 27.3 M | Britain |
 |
Adverum Biotechnologies
ADVM
|
19.8 M | - | - | $ 86.2 M | USA |
 |
Институт стволовых клеток человека
ISKJ
|
75 M | - | - | - |  Russia |
 |
ARCA biopharma
ABIO
|
16.8 M | - | 1052.0 % | $ 415 M | USA |
 |
Capricor Therapeutics
CAPR
|
26.8 M | $ 26.86 | -3.83 % | $ 719 M | USA |
 |
Acer Therapeutics
ACER
|
15.8 M | - | 2.71 % | $ 14 M | USA |
 |
Alpine Immune Sciences
ALPN
|
33.4 M | - | - | $ 2.17 B | USA |
 |
Acorda Therapeutics
ACOR
|
1.24 M | - | -24.86 % | $ 820 K | USA |
 |
Acasti Pharma
ACST
|
12.1 M | - | 4.01 % | $ 150 M | Canada |
 |
CureVac N.V.
CVAC
|
186 M | - | - | $ 867 M | Germany |
 |
Aeterna Zentaris
AEZS
|
115 M | - | 5.93 % | $ 314 M | Canada |
 |
AgeX Therapeutics
AGE
|
1.08 K | - | -10.17 % | $ 12.2 K | USA |
 |
Codexis
CDXS
|
73.4 M | $ 1.02 | - | $ 74.9 M | USA |
 |
Aeglea BioTherapeutics
AGLE
|
78.2 M | - | - | $ 1.01 B | USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
45 M | - | - | $ 26.5 M | USA |
 |
AIkido Pharma
AIKI
|
6.18 M | - | 1.93 % | $ 17.4 M | USA |
 |
Agenus
AGEN
|
358 K | $ 3.34 | 0.3 % | $ 1.2 M | USA |
 |
Ayala Pharmaceuticals
AYLA
|
15.4 M | - | - | $ 7.46 M |  Israel |
 |
Akero Therapeutics
AKRO
|
67.1 M | - | - | $ 3.67 B | USA |
 |
Agios Pharmaceuticals
AGIO
|
58 M | $ 29.2 | -3.41 % | $ 1.69 B | USA |
 |
Advaxis
ADXS
|
6.02 M | - | -9.65 % | $ 45.9 M | USA |
 |
Akouos
AKUS
|
34.4 M | - | 0.23 % | $ 488 M | USA |
 |
Завод ДИОД
DIOD
|
91.5 M | - | - | - | Russia |
 |
Фармсинтез
LIFE
|
301 M | - | - | - | Russia |
 |
Albireo Pharma
ALBO
|
19.2 M | - | -0.23 % | $ 916 M | USA |
 |
Cellectis S.A.
CLLS
|
44.8 M | $ 3.8 | -2.06 % | $ 116 M | France |
 |
Alector
ALEC
|
103 M | $ 2.21 | -9.05 % | $ 228 M | USA |
 |
Entera Bio Ltd.
ENTX
|
18.4 M | $ 1.37 | -1.44 % | $ 62.8 M | Israel |
 |
Allena Pharmaceuticals
ALNA
|
68 M | - | 3.16 % | $ 1.9 M | USA |
 |
Aileron Therapeutics
ALRN
|
17.9 M | - | 10.36 % | $ 9.8 M | USA |
 |
Altimmune
ALT
|
71 M | $ 4.16 | - | $ 295 M | USA |
 |
Teligent, Inc.
TLGT
|
5.59 M | - | -13.85 % | $ 16.1 M | USA |
 |
AlloVir
ALVR
|
5.01 M | - | 4.14 % | $ 49.1 M | USA |
 |
Viela Bio, Inc.
VIE
|
12.3 M | - | - | $ 2.91 B | USA |
 |
Ampio Pharmaceuticals
AMPE
|
810 K | - | -11.43 % | $ 502 K | USA |
 |
Amarin Corporation plc
AMRN
|
415 M | $ 13.93 | 0.94 % | $ 5.78 B |  Irlanda |
 |
AbbVie
ABBV
|
1.77 B | $ 234.26 | 0.94 % | $ 414 B | USA |
 |
Blueprint Medicines Corporation
BPMC
|
62.9 M | - | - | $ 8.14 B | USA |
 |
Applied Molecular Transport
AMTI
|
38.8 M | - | - | $ 10.1 M | USA |
 |
AIM ImmunoTech
AIM
|
48.1 M | $ 0.77 | -14.64 % | $ 37 M | USA |